MetaCap

Azora Therapeutics (AZR) vs Rani Therapeutics (RANI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Rani Therapeutics is the larger company by market cap ($59.0 million vs $55.0 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AZR-24.51%RANI-16.93%
+7%-13%-33%
Oct 28, 20261 yearNov 20, 2026
AZR+1.05%RANI-13.37%
+8%-3%-14%
Oct 26, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AZR versus RANI key metrics
MetricAZRRANI
Share price$3.85$0.5111
Market cap$55.00M$59.03M
1-day change-0.52%-11.97%
YTD return—-62.14%
1-year return—-68.64%
5-year return—-98.34%
EPS (TTM)$-18.09$-0.06
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$1.63M
Revenue growth (YoY)—+58.85%
Net income (latest FY)$-7.98M$-29.67M
Operating margin—-2345.99%
Net margin—-1817.09%
52-week high$8.25$1.69
52-week low$1.31$0.502
Distance from 52-week high-53.33%-69.76%
Analyst consensus—strong_buy
Avg. price target upside—+1308.73%
Average volume50.12K545.67K
Shares outstanding14.29M115.49M
Employees—69
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Rani Therapeutics

RANI stock →

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 69 employees

AZR vs RANI FAQ

Which is bigger, Azora Therapeutics or Rani Therapeutics?

Rani Therapeutics (RANI) is larger, with a market capitalization of $59.03M compared with $55.00M for Azora Therapeutics (AZR).

Are Azora Therapeutics and Rani Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons